+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Intravenous Equipment Market Size, Share & Industry Trends Analysis Report By Product Type (IV catheters, Infusion Pumps, Administration Sets, Needleless Connectors, and Others), By End User, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 116 Pages
  • August 2023
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5887033
The Latin America, Middle East and Africa Intravenous Equipment Market should witness market growth of 8.4% CAGR during the forecast period (2023-2030).

Developing nations are expected to drive the market due to improved healthcare infrastructure, rising unmet healthcare demands, and an increased prevalence of noncommunicable diseases, in particular diabetes and cardiovascular disease. Additionally, the desire for better healthcare services, significant government investments in enhancing the infrastructure for healthcare, and the growth of the medical tourism sector in emerging nations all contribute to the substantial growth in the healthcare sector in developing countries. The size of the market is also influenced by governments in many nations investing in healthcare infrastructure and encouraging the use of cutting-edge intravenous technology.

Additionally, ambulatory care environments, such as clinics, outpatient facilities, and ambulatory surgical centres, are expanding significantly. Intravenous therapy is often provided in these settings, which offer healthcare services without the requirement for overnight hospital stays. Since healthcare providers need dependable and effective equipment to give intravenous therapy in these settings, the growth of ambulatory care settings contributes to the demand for intravenous equipment.

According to the United Nations Industrial Development Organization’s “The Business of Health in Africa” report, despite having 11% of the world's population and 24% of the world's diseases, the region receives less than 1% of global health spending. These differences served as a catalyst for the beginning of numerous significant international financial support projects. Aid given to the region has also risen overall. Over the past ten years, Sub-Saharan Africa has received around $8 billion in aid from bilateral and multilateral donors combined. According to the information above, there will be a substantial market in the LAMEA region.

The Brazil market dominated the LAMEA Intravenous Equipment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $406.6 Million by 2030. The Argentina market is showcasing a CAGR of 9% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.1% during (2023-2030).

Based on Product Type, the market is segmented into IV catheters, Infusion Pumps, Administration Sets, Needleless Connectors, and Others. Based on End-user, the market is segmented into Hospitals & Clinics, Homecare Settings and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AngioDynamics, Inc., B. Braun Melsungen AG, ICU Medical, Inc., 3M Company, Teleflex, Inc., Terumo Corporation, Baxter International, Inc., Becton, Dickinson and Company, Vygon and Poly Medicure Limited

Scope of the Study

By Product Type

  • IV catheters
  • Infusion Pumps
  • Administration Sets
  • Needleless Connectors
  • Others

By End-user

  • Hospitals & Clinics
  • Homecare Settings
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • 3M Company
  • Teleflex, Inc.
  • Terumo Corporation
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Vygon
  • Poly Medicure Limited

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Intravenous Equipment Market, by Product Type
1.4.2 LAMEA Intravenous Equipment Market, by End User
1.4.3 LAMEA Intravenous Equipment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Intravenous Equipment Market
Chapter 5. LAMEA Intravenous Equipment Market by Product Type
5.1 LAMEA IV catheters Market by Country
5.2 LAMEA Infusion Pumps Market by Country
5.3 LAMEA Administration Sets Market by Country
5.4 LAMEA Needleless Connectors Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Intravenous Equipment Market by End User
6.1 LAMEA Hospitals & Clinics Market by Country
6.2 LAMEA Homecare Settings Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Intravenous Equipment Market by Country
7.1 Brazil Intravenous Equipment Market
7.1.1 Brazil Intravenous Equipment Market by Product Type
7.1.2 Brazil Intravenous Equipment Market by End User
7.2 Argentina Intravenous Equipment Market
7.2.1 Argentina Intravenous Equipment Market by Product Type
7.2.2 Argentina Intravenous Equipment Market by End User
7.3 UAE Intravenous Equipment Market
7.3.1 UAE Intravenous Equipment Market by Product Type
7.3.2 UAE Intravenous Equipment Market by End User
7.4 Saudi Arabia Intravenous Equipment Market
7.4.1 Saudi Arabia Intravenous Equipment Market by Product Type
7.4.2 Saudi Arabia Intravenous Equipment Market by End User
7.5 South Africa Intravenous Equipment Market
7.5.1 South Africa Intravenous Equipment Market by Product Type
7.5.2 South Africa Intravenous Equipment Market by End User
7.6 Nigeria Intravenous Equipment Market
7.6.1 Nigeria Intravenous Equipment Market by Product Type
7.6.2 Nigeria Intravenous Equipment Market by End User
7.7 Rest of LAMEA Intravenous Equipment Market
7.7.1 Rest of LAMEA Intravenous Equipment Market by Product Type
7.7.2 Rest of LAMEA Intravenous Equipment Market by End User
Chapter 8. Company Profiles
8.1 AngioDynamics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 ICU Medical, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 3M Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 Teleflex, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Terumo Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Baxter International, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Becton, Dickinson, and Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 VYGON
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Poly Medicure Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

Companies Mentioned

  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • 3M Company
  • Teleflex, Inc.
  • Terumo Corporation
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Vygon
  • Poly Medicure Limited

Methodology

Loading
LOADING...